Consulting Services
For Investors
- Lucid Diligence Briefs
- Venture Capital
Case Studies
Insights
- Conference Previews
- Conference Social Media Reports
LucidWargames
QuickAnswers
LucidSearch
BioPharma and Tech News

Contact Us

Search

Autolus

Hematology

Hematology Video Recap—December 1, 2025

This biweekly Hematology video recap highlights recent advancements in…

Hematology

Hematology Today—December 1, 2025

This week’s hematology news covers key regulatory milestones, access decisions,…

Cell_Gene_Therapy

Cell and Gene Therapy Video Recap—November 27, 2025

This biweekly Cell and Gene Therapy video reacap covers major regulatory…

Cell_Gene_Therapy

Cell and Gene Therapy Today—November 27, 2025

This week's Cell and Gene therapy update covers major regulatory approvals,…

Categories

Obesity News
Endocrinology News
Our Insights
Immunology News
Case studies
Hematology News
BioPharma and Tech News
Oncology News
BioPharma Strategy, CI and AI Guides
Lucid Diligence Brief
Conference Social Media Reports
Venture Capital
AI in Healthcare and Digital Health
Conference Previews
Cell and Gene Therapy News
Rare Disease News
Neuroscience News
Women's Health News
Public Health News
Respiratory News
Cardiovascular News
Vaccine news

Recent Posts

Public Health Today—16 January, 2026
Respiratory Today—January 16, 2026
Vaccines Today—January 16, 2026
Lucid Diligence Brief: Ocugen preliminary Phase 2 data in geographic atrophy
Cardiovascular Video Recap—January 15, 2026

Tags

AACR 2025 ABO-503 AMWC Dubai Anavex Life Sciences Bicara Therapeutics Cigna coverage COVID-19 variants CTNNB1S37F de-identification DM1 DMD exon 51 Endeavor BioMedicines geneventiv therapeutics GHD Hemgenix Major depressive disorder Microsoft biosecurity Nabla neurological epidemiology nvidia NVIDIA Blackwell ofatumumab PANTHERx Rare PARADIGM PCV13 booster PDPL Plus Therapeutics ProFound Therapeutics QuantHealth R9 Rare endocrine disorders Relief Cardiovascular SaMD SEC filings sHLH STAR-101 strabismus Taho Pharmaceuticals Taysha Gene Therapies tocilizumab-anoh TranC Verismo Therapeutics Vertex Women’s Health Fund YAP signaling

Archives

Archives

LucidQuest Ventures

Accelerate Your Success

LATEST NEWS

Public Health Today—16 January, 2026
Respiratory Today—January 16, 2026
Vaccines Today—January 16, 2026
Lucid Diligence Brief: Ocugen preliminary Phase 2 data in geographic atrophy
Cardiovascular Video Recap—January 15, 2026

TAGS

AACR 2025 ABO-503 AMWC Dubai Anavex Life Sciences Bicara Therapeutics Cigna coverage COVID-19 variants CTNNB1S37F de-identification DM1 DMD exon 51 Endeavor BioMedicines geneventiv therapeutics GHD Hemgenix Major depressive disorder Microsoft biosecurity Nabla neurological epidemiology nvidia NVIDIA Blackwell ofatumumab PANTHERx Rare PARADIGM PCV13 booster PDPL Plus Therapeutics ProFound Therapeutics QuantHealth R9 Rare endocrine disorders Relief Cardiovascular SaMD SEC filings sHLH STAR-101 strabismus Taho Pharmaceuticals Taysha Gene Therapies tocilizumab-anoh TranC Verismo Therapeutics Vertex Women’s Health Fund YAP signaling

Consulting Services
For Investors
- Lucid Diligence Briefs
- Venture Capital
Case Studies
Insights
- Conference Previews
- Conference Social Media Reports
LucidWargames
QuickAnswers
LucidSearch
BioPharma and Tech News

© 2026 LucidQuest Ventures. All rights reserved

We use cookies from third party services to offer you a better experience. Read about how we use cookies and how you can control them by clicking "Privacy Preferences".

Privacy Preference Center

Privacy Preferences

When you visit any website, it may store or retrieve information on your browser in the form of cookies. Since we respect your right to privacy, you can choose not to permit data collection from certain types of services. However, not allowing these services may impact your experience ans we are able to offer you.

Privacy Policy

Required

You read and agreed to our Privacy Policy

Tracking

We use third-party cookies that help us analyze and understand how you use this website. These cookies do not store any personal information.

Privacy Policy